Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Value Research

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

We inform you that Mr. S. Subramanian Chief Financial Officer of the Company will be interacting in person with various investors in the Kotak Institutional Equity Healthcare Forum 2022 on September 8 2022 at Kotaks office 27 BKC Mumbai.No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is submitted pursuant to Regulation 30(6) of the Listing Regulations.

Click here to view PDF


Other Categories